Naheed Misfeldt

Naheed received her BA from the University of California, Berkeley and her Master of Public Health degree from Columbia University. She has trained EMT students and others in skills associated with emergency medicine.

Naheed is focused on the formation of specialty pharma, anti-infective, and molecular diagnostics companies. 

​

She is currently a Venture Partner at Omega Funds, a dedicated global life sciences investment firm, and she is based in San Francisco. Previously Naheed spent 10 years with Aberdare Ventures, where she played an instrumental role in HermaQuest Pharmaceuticals, where she was a board member, as well as Pharmion, Mpex Pharmaceuticals, Kai Pharmaceuticals, and Clovis Oncology. 

​

Naheed joined Aberdare Ventures from Bay City Capital, a leading life sciences merchant bank, where she evaluated numerous investment opportunities in biopharmaceuticals and assisted portfolio companies in their fundraising activities. Prior to Bay City Capital, Naheed served as an Associate in the Healthcare Group at Chase H&Q, where she was involved in numerous advisory and capital-raising activities for the bank's publicly traded and privately held clients.

Naheed is a member of Kauffman Fellows Class 9 and served her fellowship under mentor Paul Klingenstein at Aberdare Ventures in San Francisco.